Companies: 10,795·Total market cap: $144.5T
Kairos Pharma, Ltd.

Kairos Pharma, Ltd.

KAPAAMEXHealthcare● Active
$0.45
+$0.01(+2.27%)
Market Cap$9635039
P/E Ratio
52W High$2.11
52W Low$0.43
Overview

Kairos Pharma, Ltd.(KAPA)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · KAPA · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.30kapa eps ttm · kapa earnings per shareEarnings history
PE Ratio (TTM)kapa pe ratio ttm · kapa price to earningsPE Ratio deep dive
Revenue (TTM)0.00kapa revenue ttm · kapa annual revenueFull revenue history
Dividend Yield不分红does kapa pay dividends · kapa dividend yieldDividend history
Shares Outstanding18.4Mkapa shares outstanding · kapa floatShares outstanding history
Next EarningsAug 11, 2026Est.kapa earnings date · kapa next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$0.00
202320242025
kairos pharma, ltd. revenue · kapa revenue 2025
FY 2025Net Income-$5.4M▼ 109.26% YoY
202320242025
kairos pharma, ltd. net income · kapa profit 2025
FY 2025EPS$-0.30▼ 30.43% YoY
202320242025
kapa eps · kairos pharma, ltd. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$5.8MEPS: $-0.30View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy1 位分析师is kapa a buy · kapa analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.45Current
$Avg Target
$High
kapa price target · kapa 12 month forecast

合计: 1 · 买入占比: 100.0%

股票表现

完整历史
1D+2.27%
1W-8.54%
1M-19.64%
3M-28.68%
YTD-36.62%
1Y-20.63%
5Y-82.69%

关于 Kairos Pharma, Ltd.

CEOJohn S. Yu
IPO DateSep 16, 2024
Employees1
CountryUS

Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of an…

what is kairos pharma, ltd. · kapa stock overview · kairos pharma, ltd. company profile · who is kairos pharma, ltd. ceo · kapa AMEX · kairos pharma, ltd. headquarters · kairos pharma, ltd. business segments

关于股票概览与关键数据

Kairos Pharma, Ltd.(KAPA)是 Biotechnology 行业的 Healthcare 类公司,于 Sep 16, 2024 在 AMEX 上市。截至最近交易日,KAPA 股价为 $0.45,市值约为 $9.6M。过去12个月累计回报 -20.63%,年初至今回报 -36.62%。

根据 1 位华尔街分析师,Kairos Pharma, Ltd. 股票共识评级为Buy,12个月平均目标价为 $—。2025 财年 Kairos Pharma, Ltd. 营收 —,净利润 -$5.4M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Kairos Pharma, Ltd.(KAPA)股价为 $0.45,在 AMEX 上市,52周区间为 $0.43 – $2.11。

KAPA 最新股价KAPA quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议